Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Science & Health
Sep 28, 2022
Shionogi says COVID-19 pill trial shows reduction in symptoms
The drug met the trial's goal of reducing five key symptoms of the omicron variant within 72 hours of onset, the company said.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer’s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer's by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
JAPAN
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizer's omicron booster can be administered to people age 12 and over, while Moderna's is limited to those 18 and above, the panel advised.
Japan Times
WORLD / Science & Health
Aug 17, 2022
Why a century-old vaccine offers new hope against pathogens
The B.C.G. tuberculosis vaccine may protect against COVID-19 and other infections by broadly bolstering the immune system.
Japan Times
JAPAN
Aug 10, 2022
Shionogi confirms efficacy of oral COVID drug for omicron subvariant
The announcement came after a health ministry panel in July postponed the granting of emergency approval for the drug.
Japan Times
JAPAN / Science & Health
Aug 9, 2022
Japan to offer omicron COVID shots to people vaccinated at least twice
The vaccines have been reported to provide some increase in neutralizing antibodies against the BA.5 subtype currently prevalent across the country.
Japan Times
WORLD / Science & Health
Jul 26, 2022
Siga and peers rise on optimism over therapies to treat monkeypox
It has been a bumpy few months for shares of firms tied to the outbreak, as investors have piled in only to rush out on uncertainty about what medicine could be needed.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer’s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
WORLD / Science & Health
Apr 27, 2022
With supply more abundant, U.S. pharmacies struggle to use up COVID pills
The rollout of the COVID-19 treatment Paxlovid has been far more complicated and less efficient than expected, leaving hundreds of thousands of courses unused.
Japan Times
BUSINESS / Companies
Apr 22, 2022
U.S. in talks with Japan's Shionogi to buy new COVID-19 pill
Shionogi's treatment is in late-stage clinical trials and hasn't yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.
Japan Times
JAPAN
Apr 13, 2022
Shionogi to recommend pregnant women not use oral COVID drug
Shionogi has filed for conditional early approval to skip the final stage of clinical trials once a certain level of efficacy and safety has been confirmed.
Japan Times
WORLD / Science & Health
Apr 12, 2022
India hopes ‘Pharma City’ will break China’s grip on industry
It's a vast project that shows how governments are growing increasingly concerned about China's stranglehold over drug supplies — as well as the challenges they face in loosening it.
Japan Times
JAPAN / Science & Health / FOCUS
Apr 3, 2022
Japan looks to accelerate vaccine research and development with new government body
The government also aims to contribute to the international community by making the vaccines produced in Japan available abroad.
Japan Times
WORLD
Mar 29, 2022
World moves from shortages to possible glut of COVID-19 vaccines
Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned.
Japan Times
BUSINESS / Companies
Mar 25, 2022
Shionogi signs supply deal with Japanese government for COVID-19 pill
The government is considering buying a million doses of the drug, pending regulatory approval.
Japan Times
BUSINESS / Companies
Mar 23, 2022
With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition
The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.
Japan Times
WORLD
Mar 16, 2022
U.S., EU, India and South Africa near deal on intellectual property waiver for COVID vaccines
The tentative agreement does not include COVID-19 treatments or tests, and also has limitations likely to exclude China from any waiver, according to one source.
Japan Times
WORLD / Science & Health
Mar 16, 2022
Pfizer asks U.S. regulator to clear another booster for older adults
The drugmaker and its partner BioNTech have submitted data to the FDA from Israel, which began offering a fourth shot to older people and health care workers last year.
Japan Times
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia's invasion of Ukraine and the needs of sick patients.
Japan Times
JAPAN
Mar 11, 2022
Fujifilm to halt enrollment in Avigan trial for COVID-19
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'